- Home
- IVA vs PROP Comparison
IVA vs PROP Comparison
Compare IVA & PROP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IVA
- PROP
- Stock Information
- Founded
- IVA 2011
- PROP 2001
- Country
- IVA France
- PROP United States
- Employees
- IVA N/A
- PROP N/A
- Industry
- IVA Biotechnology: Pharmaceutical Preparations
- PROP Investment Bankers/Brokers/Service
- Sector
- IVA Health Care
- PROP Finance
- Exchange
- IVA Nasdaq
- PROP Nasdaq
- Market Cap
- IVA 117.3M
- PROP 115.3M
- IPO Year
- IVA 2020
- PROP N/A
- Fundamental
- Price
- IVA $2.17
- PROP $8.29
- Analyst Decision
- IVA Strong Buy
- PROP
- Analyst Count
- IVA 4
- PROP 0
- Target Price
- IVA $13.25
- PROP N/A
- AVG Volume (30 Days)
- IVA 6.4K
- PROP 264.3K
- Earning Date
- IVA 09-25-2024
- PROP 01-01-0001
- Dividend Yield
- IVA N/A
- PROP N/A
- EPS Growth
- IVA N/A
- PROP N/A
- EPS
- IVA N/A
- PROP N/A
- Revenue
- IVA $20,652,523.00
- PROP $1,545,792.00
- Revenue This Year
- IVA N/A
- PROP $5,586.66
- Revenue Next Year
- IVA $361.78
- PROP $244.90
- P/E Ratio
- IVA N/A
- PROP N/A
- Revenue Growth
- IVA N/A
- PROP N/A
- 52 Week Low
- IVA $1.53
- PROP $4.91
- 52 Week High
- IVA $4.50
- PROP $16.08
- Technical
- Relative Strength Index (RSI)
- IVA 39.56
- PROP 58.94
- Support Level
- IVA $2.11
- PROP $4.91
- Resistance Level
- IVA $2.24
- PROP $7.25
- Average True Range (ATR)
- IVA 0.07
- PROP 0.89
- MACD
- IVA 0.01
- PROP 0.21
- Stochastic Oscillator
- IVA 26.58
- PROP 82.64
About IVA Inventiva S.A. American Depository Shares
Inventiva SA is a France-based biopharmaceutical company specialized in developing drugs that impact on nuclear receptors, transcription factors and epigenetic modulation. The company is focused on developing its product candidate, lanifibranor, for the treatment of patients with non-alcoholic steatohepatitis, or NASH, a disease for which there are currently no approved therapies. The company is also involved in developing a portfolio of pre-clinical therapy programs. It operates in the segment of Service delivery and clinical stage research, notably into therapies in the areas of oncology, fibrosis, and rare diseases. All the company's operations are in France. Majority of the group's revenue is derived from its research partnerships with AbbVie and BI.
About PROP Prairie Operating Co.
Prairie Operating Co develops and operates bitcoin mining scaled-up facilities using natural gas to power the operations. It generates substantially all its revenue through cryptocurrency, which it earns through mining activities.